指南与共识皮肤感染

英国皮肤科医师协会2026年真菌性甲感染(甲真菌病)管理指南

British Association of Dermatologists guideline for managing fungal nail infection (onychomycosis) 2026.
指南 / 共识 · Br J Dermatol · 2026-10-22

英国皮肤科医师协会组织专家(皮肤科顾问、药师、足病医生及患者代表)回顾已发表证据,制定44条推荐。多数患者可在基层医疗管理,复杂病例需转诊皮肤科;强调准确诊断、个体化治疗,并告知获益风险及疗程。

要点

  • 多数甲真菌病患者在基层医疗管理,复杂病例转诊皮肤科。
  • 特比萘芬为一线口服治疗,不耐受时可选伊曲康唑或氟康唑。
  • 儿童及青少年可用抗真菌药,剂量按年龄和体重调整。

核心结论

  • 甲真菌病管理应基于准确诊断,治疗决策需结合感染类型、年龄、健康状况及个人偏好。
  • 特比萘芬为多数患者一线口服治疗,不适用时可选伊曲康唑或氟康唑。
  • 应告知患者治疗获益与风险、疗程,且感染治愈后指甲外观未必恢复如初。

研究设计与样本

  • 英国皮肤科医师协会召集皮肤科顾问、药师、足病医生及有甲真菌病亲身经历者组成的专家组。
  • 专家组回顾已发表的治疗证据,制定44条推荐。

主要发现

  • 约每2000名儿童中有1例甲真菌病,65岁以上人群增至每3人中有1例。
  • 局部治疗适用于轻度感染或无法口服药物者,顽固感染可考虑联合治疗。
  • 指南提供甲真菌病管理路径、未来研究建议及审计要点。

关键数值与推荐

  • 特比萘芬为多数甲真菌病患者一线口服治疗。
  • 特比萘芬不适用时,可选用伊曲康唑或氟康唑口服。
  • 儿童及青少年抗真菌药剂量按年龄和体重调整。

临床怎么用

  • 基层医生可管理多数甲真菌病患者,复杂病例转诊皮肤科。
  • 治疗前准确诊断,治疗决策个体化并充分告知获益风险及疗程。
  • 依据管理路径选择局部或口服治疗,顽固感染考虑联合方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Fungal nail infection (FNI) is a common condition. It affects the toenails and fingernails. Fungi grow in the nail, causing thickening, discoloration or crumbling. Around 1 in 2000 children have FNI. This increases to one in three people aged over 65 years. The British Association of Dermatologists brought together a group of experts on FNI. They included consultant dermatologists, pharmacists, podiatrists and people with lived experience of FNI. The group reviewed the published evidence on treatment. This UK-based group produced 44 recommendations. Management of most people with FNI is in primary care. However, more complex cases may need referral to a dermatologist. Accurate diagnosis is important. Treatment decisions should always fit the person with FNI. Factors include the type of infection, age, general health and personal preference. People with FNI should be told the benefits and risks of treatment and how long treatment will take. Nails may not always return to their previous appearance even when the infection is cured. Topical treatments are those applied to the affected nail. These may be suitable for mild infections or for people who cannot take oral medication. For many, an oral tablet called ‘terbinafine’ is the first-line treatment. When terbinafine is not suitable, other oral tablets called ‘itraconazole’ or ‘fluconazole’ can be used. Combination approaches may be helpful for stubborn infections. Children and young people can receive antifungal medicines. Doses should be adjusted according to their age and weight. The authors present a management pathway for patients with FNI. This will guide clinicians through the treatment options. Recommendations for future research are also included. Finally, audit points are presented. These will allow hospitals to check that the care of patients with FNI is meeting the right standards.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Ameen M, Alband N, Bhatti K, et al. British Association of Dermatologists guideline for managing fungal nail infection (onychomycosis) 2026. Br J Dermatol. 2026. PMID: 42910426. doi:10.1093/bjd/ljag318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。